ArticleBMC public health2025
Global, regional and country-specific burden of larynx cancer due to occupational exposure to asbestos: a systematic analysis of the Global Burden of Disease Study 2021.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Global Burden of Hepatoblastoma From 1990 to 2021 and Projection to 2030.Cancer medicine · 2025Article
- Epidemiological study of thyroid cancer at global, regional, and national levels from 1990 to 2021: an analysis derived from the Global Burden of Disease Study 2021.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLaryngeal cancer (LC) attributable to occupational asbestos exposure remains a significant global health concern. This study aimed to assess the global burden of LC caused by asbestos exposure using data from the Global Burden of Disease (GBD) 2021 study.
methodsData from the Global Burden of Diseases study 2021 were used to analyze the global burden of LC, including incidence, mortality, prevalence, and disability-adjusted life years (DALYs) from 1990 to 2021. The study employed age-standardized rates (ASR) for comparison. Trend analysis was performed using annual percentage change (EAPC) to examine temporal changes in LC burden. Bayesian age-period-cohort modeling was utilized to project future trends from 2022 to 2046.
resultsIn 2021, the global burden of LC attributable to occupational asbestos exposure was 3,392 deaths and 66,909 DALYs. The burden was significantly higher in males compared to females. The age-standardized mortality rate was highest in high-SDI regions, but low- and middle-SDI regions showed increasing trends. From 1990 to 2021, global LC mortality and DALYs decreased, with a notable reduction in high-income countries, while many low- and middle-income countries experienced either stable or rising trends. Projections indicate continued decline in high-income countries but persistent or increasing burden in lower-income regions.
conclusionThis study highlights the ongoing global disparities in the burden of LC due to occupational asbestos exposure. While high-income countries have made significant progress in reducing this burden, low- and middle-income countries continue to face challenges due to ongoing asbestos use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.